|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
|
Galera Therapeutics, Inc. (GRTX) |
|
|
$0.18 0.00 (-0.51%) as of 4:30 Tue 5/14
|
|
Download |
|
| |
Company
Roster
|
|
Total
Insiders : |
20 |
|
|
|
Total
Direct Shares :
|
23,824,427 |
|
|
Total
Indirect Shares :
|
9,199,088 |
| |
%
Held by Insiders:
|
96.03% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Riley Dennis |
10% Owner |
|
0 |
2019-11-06 |
54,258 |
| Matthes Catherine L. |
10% Owner |
|
0 |
2019-11-06 |
52,830 |
| Pearson Mark E. |
10% Owner |
|
0 |
2023-10-31 |
5,280,000 |
| Buckler Regina A. |
10% Owner |
2019-11-06 |
54,258 |
|
0 |
| Keene Jeffrey |
10% Owner |
2019-11-06 |
54,258 |
|
0 |
| Schwarzman Stephen A |
10% Owner |
2019-11-12 |
0 |
2019-11-12 |
130,444 |
| Sandell Scott D |
10% Owner |
2019-11-12 |
4,358,047 |
2019-11-12 |
0 |
| Clarus Iv Gp L.p. |
10% Owner |
2019-11-12 |
0 |
2019-11-12 |
130,444 |
| Mehra Anand |
10% Owner |
2019-11-12 |
3,083,712 |
2019-11-12 |
0 |
| Novo A/s |
10% Owner |
2021-02-18 |
2,459,021 |
2019-11-12 |
0 |
| Schneid Yair |
10% Owner |
2024-04-19 |
10,823,610 |
|
0 |
| Sussman Joel F. |
Chief Accounting Officer |
2020-11-13 |
0 |
2020-11-12 |
0 |
| Bachleda Mark |
Chief Commercial Officer |
2023-03-16 |
11,000 |
2023-03-16 |
0 |
| Degnan Chris |
Chief Financial Officer |
2023-03-13 |
10,000 |
2023-03-13 |
0 |
| Holmlud Jon T |
Chief Medical Officer |
2021-09-01 |
0 |
2020-05-05 |
0 |
| Beardsley Robert A |
Chief Operating Officer |
2022-11-21 |
108,191 |
|
0 |
| West Linda |
Director |
2021-12-17 |
60,000 |
2021-05-28 |
0 |
| Alleva Lawrence M |
Director |
2022-07-18 |
2,325 |
2022-07-18 |
8,045 |
| Novartis Ag |
Former 10% Owner |
2020-06-19 |
2,467,961 |
2019-11-12 |
3,543,067 |
| Sorensen Mel |
President and CEO, Director |
2023-03-10 |
332,044 |
|
0 |
|
|
